Charles S. Berkman, SVP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 5,626 shares at $250.69 ($1.4M) on 2018-09-17, disclosed to the SEC on 2018-09-18.
Open-market sale of $1.4M LGND by SVP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $250.69 | 2,813 | $705K | 50.0% |
| 2 | $250.69 | 2,813 | $705K | 50.0% |
| Total | $250.69 avg | 5,626 | $1.4M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |